Drug-coated balloon for coronary artery disease
Part of Heart & circulation clinical trials.
This trial studies a balloon treatment coated with medicine (to help keep the artery open) for people with coronary artery disease. You may be a candidate if you are planned to receive this type of procedure and do not have certain key safety risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cardiologist says you are a good candidate for a drug-coated balloon (DCB) procedure
- You are not pregnant and will not be pregnant during the study
- You do not have known allergies or contraindications to the contrast dye used for imaging
- You can safely take antiplatelet medicines (blood-thinning medicines used to prevent clotting)
- You should not have contraindications to paclitaxel (the medicine used on the balloon)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
This study looks at how well a drug-coated balloon (a balloon with medicine that opens blocked heart arteries) works, either alone or with a stent, to treat coronary artery disease. It aims to see if this approach is safe and effective over time.
This study tracks outcomes in adults who receive a special balloon catheter (coated with medication) to open blocked heart arteries. Researchers collect data to understand how well this treatment works and any side effects that occur.
This study looks at how well a drug-coated balloon opens blocked heart arteries without leaving a permanent stent. It may help people who had a successful balloon procedure and want to avoid stents.
This study looks at how well drug-coated balloons work in real life for people with coronary artery disease. These balloons deliver medicine to open blocked heart arteries, and this trial aims to see how they perform in different patients.
This trial tests a treatment called a drug-coated balloon (DCB) to open narrowed heart arteries in people with type 2 diabetes. The balloon releases medicine to help keep the artery open, which may improve blood flow to the heart.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.